Mild cognitive disorders in chronic kidney disease: clinical spectrum, pathogenesis, risk factors, treatment
- Authors: Rogova I.V1, Fomin V.V1, Damulin I.V1, Mukhin N.A1
-
Affiliations:
- Issue: No 5-6 (2012)
- Pages: 4-8
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261675
- ID: 261675
Cite item
Abstract
Обсуждаются взаимосвязи хронической болезни почек и умеренных когнитивных расстройств, реализующиеся в т. ч. через общие факторы риска.
Full Text
References
- K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. American Journal of Kidney Diseases 2002;39(2):5—266.
- Clase C.M., Garg A.X., Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANESIII). J. Am. Soc. Nephrol. 2002; 13 (5): 1338-1349.
- Кутырина И.А. Ремоделирование сосудов при хронической почечной недостаточности. В кн.: Мухин Н.А. (ред.) Нефрология. Национальное руководство. М., “Гэотар-Медиа”. 2009: 608-616.
- Helmer C., Stengel B., Metzger M. et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011; 77(23): 2043-2051.
- Etgen T., Chonchol M., Förstl H. et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am. J. Nephrol. 2012; 35(5):474-482.
- Vogels S.C., Emmelot-Vonk M.H., Verhaar H.J. et al. The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas. 2012; 71(4): 331-336.
- Raphael K.L., Wei G., Greene T. et al. Cognitive function and the risk of death in chronic kidney disease. Am. J. Nephrol. 2012; 35(1): 49-57.
- Clozer M., Kuhn H., Hefti F. et al. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991;18(2): 132-141.
- Kurella M., Mapes D.L., Port F.K. et al. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2006; 21: 2543-2548.
- Pereira A.A., Weiner, D.E., Scott T. et al. Cognitive function in dialysis patients. Am. J. Kidney Dis. 2005;45: 448-462.
- Hailpern S.M., Melamed M.L., Cohen H.W. et al. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol. 2007;18:2205-2213.
- Burn D.J., Bates D. Neurology and the kidney. J. Neurol. Neurosurg. Psychiatry. 1998;65:810-821.
- Штульман Д.Р., Левин О.С. Умеренные когнитивные нарушения. Неврология. Справочник практического врача. М.: Медпресс-информ. 2005;226-229.
- Янсен В., Брукнер Г.В. Лечение хронической цереброваскулярной недостаточности с использованием драже актовегин-форте (двойное слепое плацебо-контролируемое исследование). РМЖ. 2002; 12-13:543-546.
- American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington: American Psychiatry Association. 1994.
- Левин О.С., Голубева Л.В. Гетерогенность умеренного когнитивного расстройства: диагностические и терапевтические аспекты. Консилиум. 2006;12:106-110.
- Yaffe K., Ackerson L., Kurella Tamura M. et. al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J. Am. Geriatr. Soc. 2010;58(2):338-345.
- Khatri M., Nickolas T., Moon Y.P. et al. CKD Associates with Cognitive Decline. J. Am. Soc. Nephrol. 2009;20(11):2427-2432.
- Kurella M., Yaffe K., Shlipak M.G. et al. Chronic kidney disease and cognitive impairment in menopausal women. Am. J. Kidney Dis. 2005;45:66-76.
- Elias M.F., Elias P.K., Seliger S.L. et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol. Dial. Transplant. 2009; 24: 2446-2452.
- Jassal S.K., Kritz-Silverstein D., Barrett-Connor E. A Prospective Study of Albuminuria and Cognitive Function in Older Adults. Am. J. Epidemiol. 2010;171(3): 277-286.
- Barzilay J.I., Fitzpatrick A.L., Luchsinger J. et al. Albuminuria and dementia in the elderly: a community study. Am. J. Kidney Dis. 2008;52(2):216-226.
- Kurella Tamura M., Muntner P., Wadley V. et al. Albuminuria, Kidney Function, and the Incidence of Cognitive Impairment Among Adults in the United States. Am. J. Kidney Dis. 2011.
- Kaindl A.M., Sifringer M., Koppelstaetter A. et al. Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann. Neurol. 2008;64:523-534.
- Marshall R.S., Sacco R.L., Kreuger R. et al. Dissociated vertical nystagmus and internuclear ophthalmoplegia from a midbraininfarction. Arch. Neurol. 1991;48:1304-1305.
- Дамулин И.В. Патогенетические, диагностические и терапевтические аспекты сосудистых когнитивных нарушений. Consilium Medicum. 2006;8:80-85.
- Cottone S., Mulè G., Guarneril M. et al. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol. Dial. Transplant. 2008;24:497-503.
- Pratico D., Clark C.M., Liun F. et al. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 2002;59(6):972-976.
- Sastre M., Calero M., Pawlik M. et al. Binding of cystatin C to Alzheimer’s amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol. Aging 2004;25:1033-1043.
- Yaffe K., Lindquist K., Shlipak M.G. et al. Cystatin-C as a Marker of Cognitive Function in Elders: Findings from the Health ABC Study. Ann Neurol. 2008;63(6):798-802.
- Mahoney C.A., Arieff A.I. Central and peripheral nervous system effects of chronic renal failure. Kidney Int. 1983;24:170-177.
- Agganis B.T., Weiner D.E., Giang L.M. et. al. Depression and Cognitive Function in Maintenance Hemodialysis Patients. Am. J. Kidney. Dis. 2010;56(4):704-712.
- Батюшин М.М., Постникова Е.С., Терентьев В.П. и др. Коррекция цереброренальных взаимоотношений при артериальной гипертензии, осложненной ишемическим инсультом: эффективность фиксированной комбинации эпросартана мезилата и гидрохлортиазида. Клиническая нефрология. 2009;1:59-61.
- PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041.
- Yusuf S., Sleight P., Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000;342: 145-153.
- Dahlof B., Devereux R., Kjeldsen S. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
- Baigent C., Keech A., Kearney P.M. et al. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366:1267-1278.
- Fourth Joint Task Force Of The European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur. Heart J. 2007;28:2375-2414.
- Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Методическое пособие для врачей. М., 2005:60-66.
- Petersen R.C., Stevens J.C., Ganguli M. et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1-1133.
- Feng L., Bee Yap K., Pin Ng T. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates. Am. J. Geriatr. Psychiatry.
- Jain N., Trivedi M.H., Rush A.J. et al. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials. 2012;34(1):136-144.